NCT04724031 2023-03-14
Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer
Hellenic Cooperative Oncology Group
Unknown
Clinical Trials
6 trialsNCT05392686 2022-05-26
PD1 and PARP for Maintenance Therapy in NSLLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05044091 2021-09-14
HOPEI
Jiangsu Cancer Institute & Hospital
Unknown
NCT03951415 2021-04-01
DOMEC
Leiden University Medical Center
Phase 2 Unknown
NCT03227016 2021-01-27
Study in Patients With SCLC of Veliparib in Combination With Topotecan
Central European Society for Anticancer Drug Research
Phase 1 Unknown
NCT04582552 2021-01-20
ROMP
Jiangsu Cancer Institute & Hospital
Unknown